Zhizhen Lü

909 total citations
16 papers, 777 citations indexed

About

Zhizhen Lü is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Zhizhen Lü has authored 16 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Zhizhen Lü's work include Cardiac Fibrosis and Remodeling (5 papers), Receptor Mechanisms and Signaling (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Zhizhen Lü is often cited by papers focused on Cardiac Fibrosis and Remodeling (5 papers), Receptor Mechanisms and Signaling (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Zhizhen Lü collaborates with scholars based in China, Romania and United States. Zhizhen Lü's co-authors include Youyi Zhang, Han Xiao, Yao Song, Ming Xu, Xiaowei Ma, Qiang Shen, Zijian Li, Yongnan Fu, Yi Zhu and Wei Feng and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhizhen Lü

16 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhizhen Lü China 11 473 311 141 83 75 16 777
Evangelos P. Daskalopoulos Netherlands 14 431 0.9× 279 0.9× 139 1.0× 105 1.3× 55 0.7× 31 834
Daniel A. Richards United States 14 342 0.7× 267 0.9× 89 0.6× 75 0.9× 57 0.8× 21 773
Haiyi Yu China 17 442 0.9× 375 1.2× 134 1.0× 70 0.8× 33 0.4× 52 986
Siva S. V. P. Sakamuri United States 18 356 0.8× 250 0.8× 152 1.1× 97 1.2× 99 1.3× 36 872
Loubina Fazal France 11 347 0.7× 244 0.8× 102 0.7× 55 0.7× 95 1.3× 17 650
Dajun Wang United States 11 275 0.6× 392 1.3× 111 0.8× 71 0.9× 107 1.4× 18 712
Alfonso Campanile Italy 13 451 1.0× 257 0.8× 130 0.9× 59 0.7× 71 0.9× 29 861
Bin Kong China 20 368 0.8× 342 1.1× 74 0.5× 136 1.6× 47 0.6× 62 968
Moni Nader Canada 17 458 1.0× 206 0.7× 71 0.5× 89 1.1× 57 0.8× 44 822
Delphine Baetz France 16 535 1.1× 226 0.7× 107 0.8× 42 0.5× 65 0.9× 32 820

Countries citing papers authored by Zhizhen Lü

Since Specialization
Citations

This map shows the geographic impact of Zhizhen Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhizhen Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhizhen Lü more than expected).

Fields of papers citing papers by Zhizhen Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhizhen Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhizhen Lü. The network helps show where Zhizhen Lü may publish in the future.

Co-authorship network of co-authors of Zhizhen Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Zhizhen Lü. A scholar is included among the top collaborators of Zhizhen Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhizhen Lü. Zhizhen Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xiao, Han, Hao Li, Jingjing Wang, et al.. (2017). IL-18 cleavage triggers cardiac inflammation and fibrosis upon β-adrenergic insult. European Heart Journal. 39(1). 60–69. 240 indexed citations
2.
Wu, Jimin, Yao Song, Hao Li, et al.. (2017). Metformin attenuates angiotensin II‐induced TGFβ1 expression by targeting hepatocyte nuclear factor‐4‐α. British Journal of Pharmacology. 175(8). 1217–1229. 34 indexed citations
3.
Xiao, Han, Jianshu Zhang, Mingliang Zhang, et al.. (2016). Metformin is a novel suppressor for transforming growth factor (TGF)-β1. Scientific Reports. 6(1). 28597–28597. 82 indexed citations
4.
An, Xiangbo, Jingjing Wang, Hao Li, et al.. (2016). Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy. PLoS ONE. 11(2). e0149155–e0149155. 19 indexed citations
5.
Gao, Ling, Le Chen, Zhizhen Lü, et al.. (2014). Activation of α1B-adrenoceptors contributes to intermittent hypobaric hypoxia-improved postischemic myocardial performance via inhibiting MMP-2 activation. American Journal of Physiology-Heart and Circulatory Physiology. 306(11). H1569–H1581. 12 indexed citations
6.
Li, Hao, Zhizhen Lü, Chao Chen, et al.. (2013). Echocardiographic assessment of β-adrenoceptor stimulation-induced heart failure with reduced heart rate in mice. Clinical and Experimental Pharmacology and Physiology. 41(1). 58–66. 7 indexed citations
7.
Chen, Chao, Jianhai Du, Feng Wei, et al.. (2011). β‐Adrenergic receptors stimulate interleukin‐6 production through Epac‐dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts. British Journal of Pharmacology. 166(2). 676–688. 58 indexed citations
8.
Li, Yan, Hui Zhang, Wenqiang Liao, et al.. (2011). Transactivated EGFR mediates α1-AR-induced STAT3 activation and cardiac hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology. 301(5). H1941–H1951. 29 indexed citations
9.
Xiao, Han, Xiaowei Ma, Wei Feng, et al.. (2010). Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1–Smad3 signalling pathway. Cardiovascular Research. 87(3). 504–513. 196 indexed citations
10.
Xu, Ning, Tan Zhang, Hui Zhang, et al.. (2006). Mammalian Tolloid Alters Subcellular Localization, Internalization, and Signaling of α1a-Adrenergic Receptors. Molecular Pharmacology. 70(2). 532–541. 5 indexed citations
11.
Du, Jianhai, Ning Xu, Yao Song, et al.. (2005). AICAR stimulates IL-6 production via p38 MAPK in cardiac fibroblasts in adult mice: A possible role for AMPK. Biochemical and Biophysical Research Communications. 337(4). 1139–1144. 49 indexed citations
12.
Zhang, Yongzhen, Jie Yan, Kai Chen, et al.. (2004). Different roles of α1‐adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats. Clinical and Experimental Pharmacology and Physiology. 31(9). 626–633. 12 indexed citations
13.
Yin, Feng, Zhizhen Lü, Qide Han, & Youyi Zhang. (2003). [Expression of beta2-adrenergic receptor and its effect on the proliferation of neonatal rat cardiac fibroblasts].. PubMed. 55(3). 251–4. 5 indexed citations
14.
Han, Jiangli, Youyi Zhang, Zhizhen Lü, et al.. (2003). Functional alpha1-adrenergic receptor subtypes in human right gastroepiploic artery.. PubMed. 24(4). 327–31. 4 indexed citations
15.
Wei, Hong, Zhizhen Lü, Youyi Zhang, & Qide Han. (1999). Analysis of α1-adrenoceptor subtypes in neonatal rat heart. Chinese Science Bulletin. 44(12). 1098–1101. 2 indexed citations
16.
Xu, Kaiming, Zhizhen Lü, Hong Wei, Youyi Zhang, & Chide Han. (1998). Alteration of α1-adrenoceptor subtypes in aortas of 12-month-old spontaneously hypertensive rats. European Journal of Pharmacology. 344(1). 31–36. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026